Brain-boosting substances are all the rage
Their utility is debatable
A FILM FROM 2011 entitled “Limitless” is often credited with driving an uptick in interest in products that improve focus or enhance memory. It depicts a struggling writer whose life is transformed by a smart pill. More recently the real-life version of nootropic supplements, as such boosters are called, have received celebrity endorsements. Bella Hadid, a supermodel, is behind Kin Euphorics, a brand which offers consumers the chance to “achieve an elevated state of health, mood or well-being”. Joe Rogan, the alpha-male host of the world’s most popular podcast, endorses “Alpha Brain”, which, he says, “seems to fire up” that organ.
This article appeared in the Business section of the print edition under the headline “Nootropic kid on the block”
Business March 9th 2024
- The battle over the trillion-dollar weight-loss bonanza
- Brain-boosting substances are all the rage
- More women are getting onto corporate boards. Good
- OpenAI’s legal battles are not putting off customers—yet
- Can Bayer recover from its chronic pain?
- How can firms pass on tacit knowledge?
- Apple is right not to rush headlong into generative AI
More from Business
TikTok’s time is up. Can Donald Trump save it?
The imperilled app hopes for help from an old foe
The UFC, Dana White and the rise of bloodsport entertainment
There is more to the mixed-martial-arts impresario than his friendship with Donald Trump
Will Elon Musk scrap his plan to invest in a gigafactory in Mexico?
Donald Trump’s return to the White House may have changed Tesla’s plans
Germany is going nuts for Dubai chocolate
Will the hype last?
The year ahead: a message from the CEO
From the desk of Stew Pidd
One of the biggest energy IPOs in a decade could be around the corner
Venture Global, a large American gas exporter, is going public